|
| 37830075 | Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration. | | 2023 |
| 36414127 | Unfolded protein response and angiogenesis in malignancies. | | 2023 |
| 34729828 | Quantification of myocardial fibrosis using noninvasive T2-mapping magnetic resonance imaging: Preclinical models of aging and pressure overload. | NMR in Biomedicine | 2022 |
| 36046049 | Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma. | Frontiers in Oncology | 2022 |
| 34852642 | Macrophage-Specific IGF-1 Overexpression Reduces CXCL12 Chemokine Levels and Suppresses Atherosclerotic Burden in Apoe-Deficient Mice. | Arteriosclerosis, Thrombosis, and Vascular Biology | 2022 |
| 34745017 | The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH. | Frontiers in Endocrinology | 2021 |
| 34242094 | Mutation of the 5'-untranslated region stem-loop mRNA structure reduces type I collagen deposition and arterial stiffness in male obese mice. | American Journal of Physiology - Heart and Circulatory Physiology | 2021 |
| 33781845 | Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling. | Cellular Signalling | 2021 |
| 33882908 | Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness. | Cardiovascular Diabetology | 2021 |
| 33208063 | Anti-Cancer and Anti-Bacterial Effects of -Derived Silver Nanoparticles. | Combinatorial Chemistry and High Throughput Screening | 2021 |
| 33160017 | The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion. | Cellular Signalling | 2021 |
| 32553549 | Minocycline reverses IL-17A/TRAF3IP2-mediated p38 MAPK/NF-κB/iNOS/NO-dependent cardiomyocyte contractile depression and death. | Cellular Signalling | 2020 |
| 35658745 | Levetiracetam add-on for drug-resistant focal epilepsy. | | 2020 |
| 32483202 | Targeting TRAF3IP2, Compared to Rab27, is More Effective in Suppressing the Development and Metastasis of Breast Cancer. | Scientific Reports | 2020 |
| 31862399 | Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition. | Cellular Signalling | 2020 |
| 32829657 | TRAF3IP2 (TRAF3 Interacting Protein 2) Mediates Obesity-Associated Vascular Insulin Resistance and Dysfunction in Male Mice. | Hypertension | 2020 |
| 30716386 | Minocycline inhibits PDGF-BB-induced human aortic smooth muscle cell proliferation and migration by reversing miR-221- and -222-mediated RECK suppression. | Cellular Signalling | 2019 |
| 30572805 | Breast Tumor Microenvironment Can Transform Naive Mesenchymal Stem Cells into Tumor-Forming Cells in Nude Mice. | | 2019 |
| 30909895 | The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat. | Cardiovascular Diabetology | 2019 |
| 30946636 | Angiotensin II suppresses autophagy and disrupts ultrastructural morphology and function of mitochondria in mouse skeletal muscle. | Journal of Applied Physiology | 2019 |
| 31199187 | Aldosterone impairs coronary adenosine-mediated vasodilation via reduced functional expression of Ca-activated K channels. | American Journal of Physiology - Heart and Circulatory Physiology | 2019 |
| 30038719 | TRAF3IP2, a novel therapeutic target in glioblastoma multiforme. | Oncotarget | 2018 |
| 28971844 | TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells. | American Journal of Physiology - Heart and Circulatory Physiology | 2018 |
| 29981796 | TRAF3IP2 mediates TWEAK/TWEAKR-induced pro-fibrotic responses in cultured cardiac fibroblasts and the heart. | Journal of Molecular and Cellular Cardiology | 2018 |
| 30354209 | SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis. | Arteriosclerosis, Thrombosis, and Vascular Biology | 2018 |
| 30060748 | Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury. | Cardiovascular Diabetology | 2018 |
| 28053087 | Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling. | Journal of Biological Chemistry | 2017 |
| 28977602 | Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice. | Endocrinology | 2017 |
| 28476142 | Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice. | Cardiovascular Diabetology | 2017 |
| 27659097 | Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation. | Arteriosclerosis, Thrombosis, and Vascular Biology | 2016 |
| 27237075 | TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE(-/-) mice. | Atherosclerosis | 2016 |
| 27423273 | Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone+salt-induced cardiac fibrosis in vivo. | Journal of Molecular and Cellular Cardiology | 2016 |
| 27278287 | Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferation. | Hypertension Research | 2016 |
| 27040306 | TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis. | Molecular and Cellular Endocrinology | 2016 |
| 27466370 | Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction. | Journal of Biological Chemistry | 2016 |
| 26445208 | The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4. | Journal of Cellular Physiology | 2016 |
| 26148936 | Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2. | Cellular Signalling | 2015 |
| 24561578 | OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators. | Free Radical Biology and Medicine | 2014 |
| 24265116 | Acetylsalicylic acid inhibits IL-18-induced cardiac fibroblast migration through the induction of RECK. | Journal of Cellular Physiology | 2014 |
| 24447911 | Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration. | Cellular Signalling | 2014 |
| 25038189 | Promotion of lung tumor growth by interleukin-17. | American Journal of Physiology - Lung Cellular and Molecular Physiology | 2014 |
| 25108227 | Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte death. | J Mol Cell Cardiol | 2014 |
| 23453926 | Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling. | Free Radical Biology and Medicine | 2013 |
| 24095877 | Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK. | Journal of Molecular and Cellular Cardiology | 2013 |
| 23872479 | TRAF3IP2 mediates interleukin-18-induced cardiac fibroblast migration and differentiation. | Cellular Signalling | 2013 |
| 23085260 | CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction. | Cellular Signalling | 2013 |
| 23541442 | Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin. | Cellular Signalling | 2013 |
| 22099178 | Cellular signals underlying β-adrenergic receptor mediated salivary gland enlargement. | Differentiation | 2012 |
| 22636674 | Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. | American Journal of Physiology - Heart and Circulatory Physiology | 2012 |
| 22575763 | CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy. | Journal of Molecular and Cellular Cardiology | 2012 |